Kliničke studije za Psorijaza u državi Ohio
9 studija za Psorijaza traži sudionike na lokacijama u državi Ohio.
Gradovi u državi Ohio
Službeni tekst studije (engleski)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- LEO Pharma Investigation Site, Mayfield Heights
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07013201Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Optima Research - Boardman, Boardman
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06857942Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
- University Hospitals Cleveland Medical Center, Cleveland
U tijeku regrutacija
Od 18 do 94 godina · Oba spola · Ažurirano 4. ruj 2026. · NCT06399432A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Apex Clinical Research Center - Canton, Canton
- Apex Clinical Research Center, Lorain
- Apex Clinical Research Center, Mayfield Heights
U tijeku regrutacijaFaza 3
Od 12 do 17 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06979453A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- Ppp001 50745, Columbus
- Ppp001 50202, Fairborn
- Ppp001 50733, Mayfield Heights
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 27. kol 2026. · NCT07219420A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, Mayfield Heights
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 9. srp 2026. · NCT07489885Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
- University Hospitals Cleveland Medical Center, Cleveland
U tijeku regrutacijaFaza 4
Od 18 do 89 godina · Oba spola · Ažurirano 2. tra 2026. · NCT05270733IMPACT - AndHealth Autoimmune Research Registry
- AndHealth, Columbus
U tijeku regrutacijaOpažajna studija
Od 18 do 70 godina · Oba spola · Ažurirano 29. lip 2023. · NCT05883371Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.